TTRT Picks
Hims — online TRT clinic review
Rank #19 of 20Best Brand Name

Hims Review (2026)

6.5/10from $99/mo · oral (enclomiphene)Last confirmed 2026-06-042.9 · 9,153 Trustpilot reviews

Independently researched · scored on our public 5-criteria methodology

Summarize this page with

Big-brand polish and a smooth app, but currently oral enclomiphene only — injectables expected in 2026.

Some links below may earn us a commission — see how we rank.

Hims has no signup link — Male Excel instead, which we may earn from →

Short answer

Hims scores 6.5/10 (#19 of 20 clinics) — we rate it Best Brand Name. We could not reconfirm Hims's price at our last check (2026-06-04) — treat the previously-recorded $99/mo as unconfirmed, not current. There is also a flagged concern — see Is Hims legit? below.

Our verdict

Hims earns 6.5/10 and ranks #19 of 20online TRT clinics we've scored. We rate it Best Brand Name. Big-brand polish and a smooth app, but currently oral enclomiphene only — injectables expected in 2026.

Is Hims legit?

How we checked it for this review.

Independently verified on Trustpilot: 2.9/5 from 9,153 reviews (checked 2026-08-30). 2,380 of those (26%) are from the last 12 months — a rating resting mostly on old reviews reads differently than one built on recent ones. Company-wide rating across all Hims & Hers services, not TRT-specific. See reviews →

Watch out for

In September 2025 the FDA issued warning letters to Hims & Hers over misleading marketing of its compounded GLP-1 products (claiming 'the same active ingredient' as FDA-approved Ozempic/Wegovy, which compounded drugs are not evaluated for). This is about the company's compounded-drug advertising practices broadly, not its TRT program specifically — but worth knowing when weighing marketing claims from this brand. (Source: fda.gov warning letters to Hims & Hers Health, Inc., issued 2025-09-09.)

FDA warning letters on file

Hims & Hers Health, Inc. dba Hims — MARCS-CMS 716567, issued 2025-09-09 (Center for Drug Evaluation and Research (CDER)).

FDA states it reviewed hims.com in August 2025 and cites on-site claims — "Same active ingredient as Ozempic and Wegovy", "Clinically proven ingredients" — for implying the compounded semaglutide sold is the same as the FDA-approved product. FDA states compounded drugs are not FDA-approved, making the claims false or misleading and the products misbranded under FDCA sections 502(a) and 502(bb) [21 U.S.C. §§ 352(a), 352(bb)]. Concerns the company's compounded-GLP-1 marketing broadly, not its TRT program specifically — Hims & Hers Health, Inc. is the same corporate parent trt-picks reviews under the Hims brand.

Read the letter on fda.gov →

Hims & Hers Health, Inc. dba Hers — MARCS-CMS 716825, issued 2025-09-09 (Center for Drug Evaluation and Research (CDER)).

Same-day companion letter to the one above, addressed to the same parent company's forhers.com site. FDA cites claims — "Weekly injectable GLP-1 with the same active ingredient as Ozempic and Wegovy", "Clinically proven ingredients" — on the same grounds: implying FDA-approved-equivalence for a compounded, non-FDA-approved product, in violation of FDCA sections 502(a) and 502(bb) [21 U.S.C. §§ 352(a), 352(bb)]. Included here because it names the same legal entity (Hims & Hers Health, Inc.) that operates the Hims brand this site reviews — one cap per provider regardless of letter count, per the rule.

Read the letter on fda.gov →

This is an allegation in FDA's opening enforcement communication — not an adjudicated finding of wrongdoing. See the full picture across every clinic we track →

Confirmed regulatory action on file

FTC, joined by California and Utah lawsuit against Hims & Hers Health, Inc. — filed 2026-07-29 (3:26-cv-7871 (N.D. Cal.)).

Shared consumers' sensitive health information with third-party advertising platforms owned by Meta and Snap — via customer lists and tracking technology recording on-site "Events" — despite privacy representations that this data would be protected. Also alleges Hims fails to clearly disclose that it charges consumers almost immediately after intake-form submission, and makes cancellation difficult.

Does not move Hims' transparency score further — already at the 4.0 floor from its open FDA warning letters, shown above. Disclosed on its own because it is, on its face, a more directly on-point transparency finding than the FDA letter: sharing health data with ad platforms while claiming to protect it is squarely about trust, not a marketing-claims technicality. A reader should not read "no further score movement" as "inconsequential."

Read the complaint

A government enforcement action confirming or alleging deceptive billing, cancellation, or data-handling practices caps this provider's transparency score the same way an open FDA warning letter does — one cap regardless of how many actions are on file. See our editorial policy →

“Testosterone deficiency doesn't kill people as far as we know but it is really an important symptomatic condition that affects quality of life.”

Dr. Shalender Bhasin, MD — lead investigator, TRAVERSE trial (largest randomized cardiovascular-safety study of TRT to date, ~5,200 men, New England Journal of Medicine, 2023). More on TRT safety →

Sources: Trustpilot, fda.gov warning letters to Hims & Hers Health, Inc., issued 2025-09-09.

Third-party records

What we found outside Hims's own site — BBB, its named pharmacy partner (or lack of one), and whether it publishes a real HIPAA notice.

Better Business Bureau

Not Rated · not BBB accredited (checked 2026-08-30)

Dismissed: "Hims Inc dba Selvas BLV", Austin, TX — a retail optical-goods business, unrelated name coincidence only.

This is the entity named in Hims' own open FDA warning letters (see /fda-warning-letters). A second, separate BBB filing — "Hims & Hers Inc.", San Francisco, CA, accredited since 2018, also "Not Rated" — appears to be a related corporate filing (parent/subsidiary or address-of-record difference), not confirmed as a duplicate.

Pharmacy partner

Inconclusive on a true compounding/fulfillment pharmacy partner — hims.com is fully blocked. Investor/press materials name Marius Pharmaceuticals as the maker of Hims' branded oral testosterone product; that is a drug-manufacturer relationship, not confirmed as the compounding-pharmacy relationship this category tracks, so it is not counted as "named."

HIPAA disclosure

Inconclusive — hims.com returns HTTP 403 on every page, including a likely /notice-of-privacy-practices path suggested by cached search results. We do not report a notice as confirmed published without independently loading it.

Choose Hims if

  • + You want best brand name
  • + Lower monthly price matters to you
  • + You're looking for oral (enclomiphene)

Skip Hims if

  • Transparency & Trust scores lower (4.0/10)
  • User Experience scores lower (5.0/10)
  • Treatment Options scores lower (5.5/10)

Hims pros & cons

What we like

  • + Recognized national brand
  • + Excellent digital experience
  • + Bundled meds, labs & shipping

What could be better

  • Transparency & Trust scores lower (4.0/10)
  • User Experience scores lower (5.0/10)
  • Treatment Options scores lower (5.5/10)

How much does Hims cost?

Hims starts at $99/mo. Last confirmed 2026-06-04.

Classified as “Total not verified” — see how we classify every clinic's price →

Sources: Pricing verified on hims.com

Quick facts

Our score6.5/10
Starting price$99/mo
Treatment typesoral (enclomiphene)
AvailabilityAll 50 states + DC
InsuranceTypically cash-pay (HSA/FSA often eligible)
Overall rank#19 of 20
Price verificationLast confirmed 2026-06-04

Score breakdown

Price & Value (25%)8.5
Clinical Oversight (25%)7.5
Treatment Options (20%)5.5
User Experience (15%)5.0
Transparency & Trust (15%)4.0

How Hims works

  1. 1. Online intake. Complete a medical questionnaire about your symptoms and health history.
  2. 2. Bloodwork. Because testosterone is a Schedule III controlled substance, you'll do lab testing (at-home kit or a local lab) — never a questionnaire-only prescription.
  3. 3. Clinician review & delivery. A licensed clinician reviews your labs and, if appropriate, prescribes treatment shipped discreetly to your door, with ongoing monitoring.
Hims has no signup link here — Male Excel is our next pick, and one we may earn from →

Frequently asked questions

How much does Hims cost?

Hims starts at $99/mo (last confirmed 2026-06-04). Final cost depends on your protocol and medication.

Does Hims take insurance?

Like most online TRT clinics, Hims generally operates cash-pay, though HSA/FSA funds are often eligible. Confirm directly at checkout.

Do I need bloodwork for online TRT?

Yes. Testosterone is a Schedule III controlled substance, so reputable clinics require lab work and ongoing monitoring — never a questionnaire-only prescription.

Is Hims available in my state?

Hims is available in All 50 states + DC. Telehealth TRT rules vary by state.

Alternatives to Hims

Defy Medical

8.2

Price on consultation · injections, cream

1st Optimal

8.1

from $169/mo · injections, peptides

Viking Alternative Medicine

8.1

from $130/mo · injections, topical gels

Male Excel

8.0

from $99/mo · daily microdosing, cream

DudeMeds

8.0

from $77/mo · injections, oral (enclomiphene)

Compare all by price →

Helpful tools

Compare Hims vs other clinics

Hims has no signup link — Male Excel is our next pick, and one we may earn from.

Visit Male Excel →

Top picks

Defy Medical

8.2

Price on consultation

1st Optimal

8.1

from $169/mo

Viking Alternative Medicine

8.1

from $130/mo

Alexandru Vieru · Founder & Editor

Alexandru Vieru is the founder and editor of TRT Picks. He independently researches and verifies every clinic's pricing, treatment options and policies, and maintains the 5-point scoring model used across the site. He is not a licensed medical professional — every clinical claim is sourced to a primary reference (FDA, manufacturer pages, or peer-reviewed studies), and nothing here is medical advice.

Last confirmed 2026-06-04. Scores are derived from our documented methodology and are never influenced by affiliate commissions. Educational information only — not medical advice.